Literature DB >> 8779138

Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection.

K Kubo1, S Yamaguchi, K Fujimoto, M Hanaoka, M Hayasaka, T Honda, T Sodeyama, K Kiyosawa.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) infection has recently been incriminated as an aetiological agent in idiopathic pulmonary fibrosis. This study was performed to determine the cellularity and lymphocyte phenotypes of bronchoalveolar lavage (BAL) fluid in patients with chronic hepatitis C.
METHODS: BAL fluid and lavage lymphocyte subsets from 13 patients (10 men) with active chronic hepatitis C, diagnosed by sustained elevated serum glutamic pyruvic transaminase and typical histological findings in the liver, were analysed. Lavage findings in these patients were compared with those from 13 healthy volunteers (eight men) as controls.
RESULTS: There was no difference in total cell counts in lavage fluid between the two groups. Lavage lymphocyte and eosinophil numbers were increased in patients with chronic hepatitis C. Surface marker analysis of the lymphocyte populations showed increases in CD2, CD3, CD4, and HLA-DR. CD4/CD8 ratios were not different.
CONCLUSIONS: The numbers of lymphocytes and eosinophils in BAL fluid are increased in patients with chronic hepatitis C. These findings suggest that HCV infection may trigger alveolitis.

Entities:  

Mesh:

Year:  1996        PMID: 8779138      PMCID: PMC1090646          DOI: 10.1136/thx.51.3.312

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  12 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Characteristics of monoclonal antibody measurements in human peripheral blood.

Authors:  J T Thornthwaite; D Seckinger; P Rosenthal; A Vazquez
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

Review 3.  Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts).

Authors:  R G Crystal; P B Bitterman; S I Rennard; A J Hance; B A Keogh
Journal:  N Engl J Med       Date:  1984-01-19       Impact factor: 91.245

4.  Clinical and histological aspects of chronic HCV infection and cirrhosis.

Authors:  G Giusti; G Pasquale; D Galante; M Russo; C Sardaro; C Gallo; G B Gaeta
Journal:  Hepatogastroenterology       Date:  1993-08

5.  Prognostic role of eosinophils in pulmonary fibrosis.

Authors:  M W Peterson; M Monick; G W Hunninghake
Journal:  Chest       Date:  1987-07       Impact factor: 9.410

6.  Idiopathic pulmonary fibrosis and hepatitis C virus infection.

Authors:  W L Irving; S Day; I D Johnston
Journal:  Am Rev Respir Dis       Date:  1993-12

7.  Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus.

Authors:  T Ueda; K Ohta; N Suzuki; M Yamaguchi; K Hirai; T Horiuchi; J Watanabe; T Miyamoto; K Ito
Journal:  Am Rev Respir Dis       Date:  1992-07

8.  Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis.

Authors:  H Noguchi; G M Kephart; T V Colby; G J Gleich
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

9.  Flow cytometry CD4+/CD8+ ratio of liver-derived lymphocytes correlates with viral replication in chronic hepatitis B.

Authors:  B N Pham; J F Mosnier; F Walker; C Njapoum; F Bougy; C Degott; S Erlinger; J H Cohen; F Degos
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

10.  Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

Authors:  I G McFarlane; H M Smith; P J Johnson; G P Bray; D Vergani; R Williams
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

View more
  8 in total

Review 1.  Hepatitis C as a systemic disease: virus and host immunologic responses underlie hepatic and extrahepatic manifestations.

Authors:  Chiaki Okuse; Hiroshi Yotsuyanagi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2007-11-22       Impact factor: 7.527

Review 2.  Immunophenotyping of bronchoalveolar lavage lymphocytes.

Authors:  R J Harbeck
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

3.  Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis: A Meta-Analysis.

Authors:  Gaohong Sheng; Peng Chen; Yanqiu Wei; Huihui Yue; Jiaojiao Chu; Jianping Zhao; Yihua Wang; Wanguang Zhang; Hui-Lan Zhang
Journal:  Chest       Date:  2019-11-12       Impact factor: 9.410

4.  Hepatitis C virus infection is not an independent risk factor for obstructive lung disease.

Authors:  William A Fischer; Michael B Drummond; Christian A Merlo; David L Thomas; Robert Brown; Shruti H Mehta; Robert A Wise; Greg D Kirk
Journal:  COPD       Date:  2013-07-17       Impact factor: 2.409

5.  HIV infection is associated with diffusing capacity impairment in women.

Authors:  Meghan E Fitzpatrick; Matthew R Gingo; Cathy Kessinger; Lorrie Lucht; Eric Kleerup; Ruth M Greenblatt; David Claman; Claudia Ponath; Serena Fong; Laurence Huang; Alison Morris
Journal:  J Acquir Immune Defic Syndr       Date:  2013-11-01       Impact factor: 3.731

6.  Hepatitis C and pulmonary fibrosis: Hepatitis C and pulmonary fibrosis.

Authors:  Rasoul Aliannejad; Mostafa Ghanei
Journal:  Hepat Mon       Date:  2011-02       Impact factor: 0.660

Review 7.  Hepatitis C virus and autoimmunity.

Authors:  Barbara C Böckle; Norbert T Sepp
Journal:  Auto Immun Highlights       Date:  2010-07-10

Review 8.  Role of Microbial Agents in Pulmonary Fibrosis
.

Authors:  Ozioma S Chioma; Wonder P Drake
Journal:  Yale J Biol Med       Date:  2017-06-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.